MWNA
CORT icon

Marshall Wace North America’s Corcept Therapeutics CORT Stock Holding History

Marshall Wace North America’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-27,177
Closed -$711K – 1549
2020
Q4 		$711K Sell
27,177
-210,813
-89% -$4.44M ﹤0.01% 1018
2020
Q3 		$4.14M Buy
+237,990
New +$3.79M 0.03% 432
2020
Q2 		– Sell
-117,644
Closed -$1.4M – 1203
2020
Q1 		$1.4M Buy
117,644
+99,664
+554% +$1.23M 0.01% 555
2019
Q4 		$217K Buy
+17,980
New +$250K ﹤0.01% 957
2019
Q3 		– Sell
-81,348
Closed -$907K – 1341
2019
Q2 		$907K Sell
81,348
-47,787
-37% -$532K 0.01% 780
2019
Q1 		$1.52M Sell
129,135
-17,288
-12% -$215K 0.01% 581
2018
Q4 		$1.96M Buy
+146,423
New +$1.94M 0.02% 434
2018
Q3 		– Sell
-65,012
Closed -$1.02M – 985
2018
Q2 		$1.02M Sell
65,012
-256,252
-80% -$4.46M 0.01% 923
2018
Q1 		$5.29M Buy
+321,264
New +$5.95M 0.03% 556
2017
Q4 		– Sell
-466,460
Closed -$8.86M – 1402
2017
Q3 		$8.86M Sell
466,460
-695,370
-60% -$10.4M 0.06% 397
2017
Q2 		$13.9M Buy
+1,161,830
New +$12.6M 0.1% 247

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Marshall Wace North America's CORT Position: Q1 2021 in Review

Marshall Wace North America sold out of Corcept Therapeutics (CORT) in Q1 2021, closing a stake of 27,177 shares — an estimated $711K sold.

Marshall Wace North America first reported a position in CORT in Q2 2017 and held it in 11 quarters. The position peaked at $13.9M in Q2 2017. 209 funds tracked by Wall St. Rank hold CORT as of Q1 2021.

  • Marshall Wace North America reported no remaining Corcept Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Marshall Wace North America sold 27,177 Corcept Therapeutics shares in Q1 2021, an estimated $711K.
  • Marshall Wace North America first reported a position in Corcept Therapeutics in Q2 2017 and held it in 11 quarters.
  • Marshall Wace North America's Corcept Therapeutics position peaked at $13.9M in Q2 2017.
  • 209 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2021.

Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.